Diagnosed with a rare and aggressive brain cancer at 28, Conor Flood is running the Manchester 10k just one month after completing chemotherapy. His goal: to raise awareness and as much money as possible for the charities and research centres that have played a pivotal role in his treatment.
The Manchester neuro-oncology service, hosted at Salford Royal Hospital (part of Northern Care Alliance NHS Foundation Trust) in partnership with The Christie NHS Foundation Trust, has again been recognised as a Tessa Jowell Centre of Excellence for the care and treatment of patients with brain and spinal tumours.
Being diagnosed with a brain tumour at the age of 12 had life-changing effects on Emma Hall – but it also inspired her to become a cancer researcher and a Young Ambassador for The Brain Tumour Charity.
The Christie NHS Foundation Trust in Manchester is leading a groundbreaking clinical trial that could transform the treatment of glioblastoma, the most aggressive and deadly form of brain cancer. Known as PORTRAIT, the trial is recruiting newly diagnosed patients to explore whether treatment can begin immediately after diagnosis—before surgery and radiotherapy—using an innovative, non-invasive technology.
The third episode of The Brain Fix podcast series is talking all things Jeff!
In this episode, Professors David Brough and Omar Pathmanaban discuss the Geoffrey Jefferson Brain Research Centre, also known as The Jeff. David and Omar are joined by The Jeff co-directors Professors Stuart Allan and Andrew King who discuss the development, goals and future of our translational neuroscience centre.
We are delighted to announce that the Manchester Epilepsy Research Network (MERN) has joined the Centre as a new epilepsy research theme.
Brain Health Day successfully united researchers, medical professionals, and the public for a day dedicated to brain health awareness and education. Supported by the ARUK North West Network, attendees had the opportunity to learn about brain diseases such as stroke, dementia, Parkinson’s disease, and brain tumours.
Rare Disease Day is a pivotal time to raise awareness and support for those living with rare conditions such as Neurofibromatosis type 2-related Schwannomatosis (NF2-SWN). Read about the research that NF2BioSolutions funded PhD student Reygn Done is working on…
Join us on Saturday 15 March at Friends’ Meeting House in Manchester City Centre for an enlightening day dedicated to brain health. Discover more about brain diseases such as stroke, dementia, brain tumours and Parkinson’s disease including a special screening of The Parkinson’s Project. The event is free to attend and open to the public – everyone is welcome.
Lindonlight Collective has awarded $1.97 million to our Chair of Translational Neuro-Oncology Professor Petra Hamerlik for her pioneering work on pediatric low-grade gliomas.
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Recent Comments